US Stocks Open Lower; Dow Drops 250 Points
U.S. stocks traded lower this morning, with the Dow Jones dropping around 250 points on Friday.
Silo Pharma Announces Study Results Of SPU- 21 For Arthritis; Co. Reports ‘SPU-21 effective in controlling arthritis progression’
Silo Pharma, Inc. (NASDAQ:SILO) (“the Company”), a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research, today announced positive interim data
Silo Pharma Initiates Study Of Novel Joint Homing Peptide In Human Tissue
Silo Pharma, Inc. (NASDAQ:SILO) ("the Company"), a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research, today announced its plans to
Novel Psychedelic Compound For The Treatment Of Fibromyalgia Begins Dosing In Safety Trial
Developmental-stage psychedelics biotech company Silo Pharma Inc. (NASDAQ: SILO) has begu
Silo Pharma Extends Alzheimer’s Therapeutics Research Pact
Silo Pharma Inc (NASDAQ:SILO) entered into an agreement with Columbia University under which Silo has been granted an extension…
Why Twin Vee Powercats Is Trading Lower By Over 30%; Here Are 30 Stocks Moving Premarket
Gainers
Windtree Therapeutics, Inc (NASDAQ: WINT) rose 50.7% to $0.4827 in pre-market trading after the company said Istaroxime Phase 2 study in early cardiogenic shock was published in the European Journal of Heart Failure.
Psychedelics Capital Markets: Silo Pharma’s IPO, $5M Common Stock Offering
Developmental-stage biopharma company Silo Pharma Inc. (NASDAQ: SILO) announced the pricing of an underwritten public offering of 1,000,000 shares of its common stock at $5.00 per share, to begin trading on NASDAQ on Tuesday, September 27, 2022 under trading symbol “SILO.”